sábado, 17 de octubre de 2020

Trial Enrolling CF Patients With Digestive Enzyme Deficiency in Europe

Trial Enrolling CF Patients With Digestive Enzyme Deficiency in Europe

CF News Today's Daily Digest
Your Online Resource for the Latest CF News
In the 10/16/2020 edition:

Trial Enrolling Patients With Severe Digestive Enzyme Deficiency in Europe

By Patricia Inacio, PhD on Oct 16, 2020 07:00 am
exocrine pancreatic insufficiency studyA Phase 2 clinical trial investigating MS1819 in combination with stable pancreatic enzyme replacement therapy (PERT) to treat exocrine pancreatic insufficiency (EPI) in people with cystic fibrosis (CF) is actively recruiting participants in Europe, AzurRx BioPharma, the treatment’s developer, announced. The open-label study (NCT04302662) expects to enroll 24 CF patients, ages 12 and older, with severe EPI who failed to respond fully to […]
Continue reading

New Inhaled Therapy IONIS-ENAC-2.5Rx Shows Promise in Phase 1/2a Trial

By Teresa Carvalho on Oct 15, 2020 07:00 am
IONIS-ENAC-2.5Rx, inhaled therapyIonis Pharmaceuticals’ investigational inhaled therapy IONIS-ENAC-2.5Rx showed promise in a Phase 1/2a study as a potential new treatment for cystic fibrosis (CF), the company announced, citing trial data. That clinical data showed that ENAC-2.5Rx led to a reduction in the expression of ENaC, a sodium transport channel that’s highly increased in the lungs of people […]
Continue reading

Recent Articles:

Toronto Scientist Wins Award for Work Into Alternative Way of Treating CF
If You’ve Lost Hope, Read This
Trial of Oral CB-280 for Chronic Lung Infections in CF Enrolling Across US
The ‘5-year Plan’ Is Not for the Chronically Ill
Contemplating Our Identity

No hay comentarios:

Publicar un comentario